Cyclopentanepropanoic acid → N-5-Quinolinyl-cyclopentanepropanamide

HRID 2217814

반응식

HRID 2217814 반응식
[N:1]1[C:10]2[CH:9]=[CH:8][CH:7]=[C:6]([NH2:11])[C:5]=2[CH:4]=[CH:3][CH:2]=1.[CH:12]1([CH2:17][CH2:18][C:19](O)=[O:20])[CH2:16][CH2:15][CH2:14][CH2:13]1>>[N:1]1[C:10]2[C:5](=[C:6]([NH:11][C:19](=[O:20])[CH2:18][CH2:17][CH:12]3[CH2:16][CH2:15][CH2:14][CH2:13]3)[CH:7]=[CH:8][CH:9]=2)[CH:4]=[CH:3][CH:2]=1

참가 물질

3

반응물 2

HCID 8818Cyclopentanepropanoic acidHCID 119115-Aminoquinoline

생성물 1

HCID 2107517N-5-Quinolinyl-cyclopentanepropanamide수율 24.1%

실험 절차

Prepared according to the method of example 18, using 5-quinolinamine (250 mg) and cyclopentanepropanoic acid (270 mg). Purification (HPLC, Symmetry—0.1% aqueous trifluoroacetic acid/acetonitrile) followed by recrystallisation from methanol/ethyl acetate gave the title compound as a colourless solid (112 mg).

후처리

  1. customPrepared
  2. customPurification (HPLC, Symmetry—0.1% aqueous trifluoroacetic acid/acetonitrile)
  3. customfollowed by recrystallisation from methanol/ethyl acetate

출처 및 근거

ORD 기록
ord-a80433abb70a48ee91e47047b46d9861
출처 데이터셋
uspto-grants-2008_08
특허 번호
US07408065B2

연결된 노트

불러오는 중…